GILD

Gilead Sciences, Inc. News Headlines

$108.45
*  
2.91
2.76%
Get GILD Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Gilead's Harvoni Receives Notice of Compliance from Canada - Analyst Blog
10/17/2014 3:30:00 PM - Zacks.com


A Harvoni Vs. Olysio Price War Will Be Nonexistent: Consider Buying Gilead Now
10/17/2014 1:54:00 PM - Seeking Alpha


IYH, GILD, TMO, COV: Large Outflows Detected at ETF
10/17/2014 10:10:41 AM - BNK Invest


Will Sagging Scripts Dent Gilead Sciences, Inc. Earnings?
10/17/2014 7:30:03 AM - Motley Fool


2 Companies That Don't Deserve This Market Beatdown
10/16/2014 8:14:00 AM - Seeking Alpha


3 Reasons AbbVie's Stock Could Rise
10/16/2014 7:02:03 AM - Motley Fool


Novavax Begins Mid-Stage Study on RSV Vaccine in Elders - Analyst Blog
10/15/2014 4:20:00 PM - Zacks.com


Best U.S. Stock Ideas Today
10/15/2014 3:57:00 PM - Seeking Alpha


Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog
10/15/2014 12:59:00 PM - Zacks.com


Should Gilead Sciences, inc. Fear Incoming Competition?
10/15/2014 12:17:02 PM - Motley Fool


Healthcare ETFs in Focus on JNJ Earnings Beat - ETF News And Commentary
10/15/2014 12:00:01 PM - Zacks.com


A Review Of Gilead's Harvoni, And Competitive Considerations
10/15/2014 11:20:00 AM - Seeking Alpha


Gilead's Harvoni Will Dominate J&J's Olysio In HCV: Is Olysio Even Relevant Anymore?
10/15/2014 9:24:00 AM - Seeking Alpha


Gilead Has Taken A Pounding But Is Almost At A Level That I Want To Buy
10/15/2014 7:48:00 AM - Seeking Alpha


Gilead Sciences: Ignore Recent Insider Selling
10/14/2014 4:32:00 PM - Seeking Alpha


S&P 500 Movers: GILD, CCI
10/14/2014 2:14:26 PM - BNK Invest


Nasdaq 100 Movers: GILD, SYMC
10/14/2014 2:13:26 PM - BNK Invest


Gilead Sciences president and COO sells 146,895 shares
10/14/2014 12:05:00 PM - InvestorsObserver


With Harvoni Approved, Here's What's Next For Gilead Sciences
10/14/2014 10:06:00 AM - Seeking Alpha


3 Best-In-Class Growth Stocks To Buy On The Market Pullback
10/14/2014 9:59:00 AM - Seeking Alpha


Gilead Sciences Inc. (GILD) Has Suddenly Spiked To The Downside
10/14/2014 9:54:00 AM - RTT News


Safe Harbor Equities In A Spooky Market
10/13/2014 4:16:00 PM - Seeking Alpha


Gilead's All-Oral Combo HCV Drug Harvoni Cleared by FDA - Analyst Blog
10/13/2014 4:00:00 PM - Zacks.com


Updating My Price Target On Gilead Sciences
10/13/2014 10:23:00 AM - Seeking Alpha


Big Swings in Biotech Short Interest
10/13/2014 7:32:00 AM - Investopedia